Heteromerization between α2A adrenoceptors and different polymorphic variants of the dopamine D4 receptor determines pharmacological and functional differences. Implications for impulsive-control disorders.
Pharmacol Res
; 170: 105745, 2021 08.
Article
in En
| MEDLINE
| ID: mdl-34182128
Key words
870 trihydrochloride (PubChem CID: 49759035); A-412997 dihydrochloride (PubChem CID: 90488953); ADHD; BRL44408 maleate (PubChem CID: 10382026); Cerebral cortex; Clonidine hydrochloride (PubChem CID: 20179); Dexmedetomidine hydrochloride (PubChem CID: 6918081); Dopamine D(4) receptor; GPCR; Guanfacine hydrochloride (PubChem CID: 71401); L-745; Pramipexole dihydrochloride (PubChem CID: 119569); RX821002 hydrochloride (PubChem CID: 11957683); Receptor heteromer; Ropinirole (PubChem CID: 5095); Rotigotine hydrochloride (PubChem CID: 180335); α(2A) adrenoceptor
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Attention Deficit Disorder with Hyperactivity
/
Cerebral Cortex
/
Receptors, Adrenergic, alpha-2
/
Receptors, Dopamine D4
Limits:
Animals
/
Female
/
Humans
/
Male
Language:
En
Journal:
Pharmacol Res
Journal subject:
FARMACOLOGIA
Year:
2021
Type:
Article
Affiliation country:
Spain